The dual role of curcumin and ferulic acid in counteracting chemoresistance and cisplatin-induced ototoxicity

[1]  L. Rybak,et al.  Oral Administration of Caffeine Exacerbates Cisplatin-Induced Hearing Loss , 2019, Scientific Reports.

[2]  A. Fetoni,et al.  Targeting dysregulation of redox homeostasis in noise-induced hearing loss: Oxidative stress and ROS signaling. , 2019, Free radical biology & medicine.

[3]  Carine Smith,et al.  Are polyphenol antioxidants at the root of medicinal plant anti-cancer success? , 2019, Journal of ethnopharmacology.

[4]  J. Lindsay,et al.  New Therapeutic Strategies , 2019, Inflammatory Bowel Disease Nursing Manual.

[5]  F. Mammano,et al.  Cx26 partial loss causes accelerated presbycusis by redox imbalance and dysregulation of Nfr2 pathway , 2018, Redox biology.

[6]  A. Dinkova-Kostova,et al.  The role of Nrf2 signaling in counteracting neurodegenerative diseases , 2018, The FEBS journal.

[7]  M. Hall,et al.  Cisplatin is retained in the cochlea indefinitely following chemotherapy , 2017, Nature Communications.

[8]  L. Rybak,et al.  Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection , 2017, Front. Cell. Neurosci..

[9]  C. Hagedorn,et al.  Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture , 2017, Scientific Reports.

[10]  G. Lomberk,et al.  Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss , 2017, Front. Cell. Neurosci..

[11]  B. Water,et al.  Comprehensive Landscape of Nrf2 and p53 Pathway Activation Dynamics by Oxidative Stress and DNA Damage. , 2017, Chemical research in toxicology.

[12]  A. Sahebkar,et al.  Curcumin: A potentially powerful tool to reverse cisplatin‐induced toxicity , 2017, Pharmacological research.

[13]  S. Prasad,et al.  Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. , 2017, Cancer letters.

[14]  Akhileshwar Namani,et al.  Nrf2 signaling pathway: Pivotal roles in inflammation. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[15]  D. Baltimore,et al.  30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology , 2017, Cell.

[16]  J. Bourien,et al.  Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy , 2016, EMBO molecular medicine.

[17]  R. Schilling.  Curcumin And Cancer , 2017 .

[18]  Yulong Yin,et al.  Oxidative Stress and Inflammation: What Polyphenols Can Do for Us? , 2016, Oxidative medicine and cellular longevity.

[19]  R. Frisina,et al.  Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  S. Giordano,et al.  The Dual Roles of NRF2 in Cancer. , 2016, Trends in molecular medicine.

[21]  A. Fetoni,et al.  Audiological Monitoring in Children Treated with Platinum Chemotherapy , 2016, Audiology and Neurotology.

[22]  T. Mak,et al.  TNF and ROS Crosstalk in Inflammation. , 2016, Trends in cell biology.

[23]  Emma L. Smith,et al.  The Regulation of NF-κB Subunits by Phosphorylation , 2016, Cells.

[24]  A. Mileo,et al.  Polyphenols as Modulator of Oxidative Stress in Cancer Disease: New Therapeutic Strategies , 2015, Oxidative medicine and cellular longevity.

[25]  T. Efferth,et al.  Hormesis: Decoding Two Sides of the Same Coin , 2015, Pharmaceuticals.

[26]  A. Fetoni,et al.  Molecular targets for anticancer redox chemotherapy and cisplatin-induced ototoxicity: the role of curcumin on pSTAT3 and Nrf-2 signalling , 2015, British Journal of Cancer.

[27]  A. Fetoni,et al.  Rosmarinic acid up-regulates the noise-activated Nrf2/HO-1 pathway and protects against noise-induced injury in rat cochlea. , 2015, Free radical biology & medicine.

[28]  K. Nakagawa,et al.  Synergistic inhibition of cancer cell proliferation with a combination of δ-tocotrienol and ferulic acid. , 2014, Biochemical and biophysical research communications.

[29]  P. Tchounwou,et al.  Cisplatin in cancer therapy: molecular mechanisms of action. , 2014, European journal of pharmacology.

[30]  A. Fetoni,et al.  Curcuma Longa (Curcumin) Decreases In Vivo Cisplatin-Induced Ototoxicity Through Heme Oxygenase-1 Induction , 2014, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.

[31]  L. Galluzzi,et al.  Systems biology of cisplatin resistance: past, present and future , 2014, Cell Death and Disease.

[32]  A. Cuadrado,et al.  Transcription Factors NRF2 and NF-κB Are Coordinated Effectors of the Rho Family, GTP-binding Protein RAC1 during Inflammation* , 2014, The Journal of Biological Chemistry.

[33]  A. Fetoni,et al.  A putative role of p53 pathway against impulse noise induced damage as demonstrated by protection with pifithrin-alpha and a Src inhibitor , 2014, Neuroscience Research.

[34]  R. Foresti,et al.  Heme oxygenase-1 as a target for drug discovery. , 2014, Antioxidants & redox signaling.

[35]  C. Mancuso,et al.  Ferulic acid: pharmacological and toxicological aspects. , 2014, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[36]  D. Lane,et al.  Drugging the p53 pathway: understanding the route to clinical efficacy , 2014, Nature Reviews Drug Discovery.

[37]  S. Niture,et al.  Regulation of Nrf2-an update. , 2014, Free radical biology & medicine.

[38]  Donna D. Zhang,et al.  The emerging role of the Nrf2–Keap1 signaling pathway in cancer , 2013, Genes & development.

[39]  J. Schacht,et al.  The mitochondrion: A perpetrator of acquired hearing loss , 2013, Hearing Research.

[40]  K. O'Byrne,et al.  Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy , 2013, Front. Oncol..

[41]  Donna D. Zhang,et al.  Does Nrf2 contribute to p53-mediated control of cell survival and death? , 2012, Antioxidants & redox signaling.

[42]  D. Butterfield,et al.  Lack of p53 decreases basal oxidative stress levels in the brain through upregulation of thioredoxin-1, biliverdin reductase-A, manganese superoxide dismutase, and nuclear factor kappa-B. , 2012, Antioxidants & redox signaling.

[43]  L. Galluzzi,et al.  Molecular mechanisms of cisplatin resistance , 2012, Oncogene.

[44]  S. Ghosh,et al.  Celebrating 25 years of NF‐κB research , 2012, Immunological reviews.

[45]  N. Perkins,et al.  The diverse and complex roles of NF-κB subunits in cancer , 2012, Nature Reviews Cancer.

[46]  L. Rybak,et al.  Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation , 2011, Cell Death and Disease.

[47]  Anna R. Fetoni,et al.  Pathogenesis of presbycusis in animal models: A review , 2011, Experimental Gerontology.

[48]  M. Kwak,et al.  Transcription factor Nrf2 maintains the basal expression of Mdm2: An implication of the regulation of p53 signaling by Nrf2. , 2011, Archives of biochemistry and biophysics.

[49]  Hongyu Zhou,et al.  The targets of curcumin. , 2011, Current drug targets.

[50]  B. Aggarwal,et al.  Oxidative stress, inflammation, and cancer: how are they linked? , 2010, Free radical biology & medicine.

[51]  R. Tsao.  Chemistry and Biochemistry of Dietary Polyphenols , 2010, Nutrients.

[52]  R. Piacentini,et al.  In vivo protective effect of ferulic acid against noise-induced hearing loss in the guinea-pig , 2010, Neuroscience.

[53]  M. Karin,et al.  Dangerous liaisons: STAT3 and NF- κ B collaboration and crosstalk in cancer , 2010 .

[54]  L. Rybak,et al.  Cisplatin ototoxicity and protection: clinical and experimental studies. , 2009, The Tohoku journal of experimental medicine.

[55]  S. Niture,et al.  Nrf2:inrf2 (keap1) Signaling in Oxidative Stress , 2022 .

[56]  M. Kwak,et al.  Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance. , 2008, Cancer letters.

[57]  L. Kèlland,et al.  The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.

[58]  L. Rybak,et al.  Mechanisms of cisplatin-induced ototoxicity and prevention , 2007, Hearing Research.

[59]  C. Löwbeer.  IN CLINICAL AND EXPERIMENTAL STUDIES , 2007 .

[60]  Dong Wang,et al.  Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.

[61]  G. Bokoch.  Regulation of innate immunity by Rho GTPases. , 2005, Trends in cell biology.

[62]  P. Johnston,et al.  Molecular mechanisms of drug resistance , 2005, The Journal of pathology.

[63]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[64]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[65]  Jing Wang,et al.  Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig , 2003, Neuropharmacology.

[66]  M. Oren,et al.  Decision making by p53: life, death and cancer , 2003, Cell Death and Differentiation.

[67]  Robert C. Wolpert,et al.  A Review of the , 1985 .